VG

Vivek Giri

Active Director Director DIN 08811959
DIN 08811959 First appointment Jul 2020 Primary industry Home Appliances
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2020
Shareholding value •••• Premium profile

About Vivek Giri

Data last updated:

Vivek Giri is a Director at Runkem Pharmaceuticals Private Limited (since 2020). The company operates in Home Appliances. Runkem Pharmaceuticals Private Limited reported revenue of ₹4.8 Lakh (FY 2025).

DIN 08811959
Primary Designation Director
Industry Home Appliances
First Appointment 28 Jul 2020
Oldest Company Age 6 yrs
Largest company Runkem Pharmaceuticals Private Limited · ₹4.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Jul 20202020₹4.8 Lakh (FY 2025)Active

Board colleagues of Vivek Giri

NameDINCompanyDesignation
Kaushal Goswami08811960Runkem Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Runkem Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Vivek Giri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vivek Giri

Vivek Giri currently holds 1 directorship: Runkem Pharmaceuticals Private Limited (Director, since 28 Jul 2020, revenue ₹4.8 Lakh (FY 2025)).

Vivek Giri was first appointed on 28 Jul 2020 as Director at Runkem Pharmaceuticals Private Limited.

The current boards of Vivek Giri's companies include Kaushal Goswami (Runkem Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available